Completed Brain & Nervous System Genetics & Molecular Biology

Reversibility and Mapping of Rett Syndrome-like Phenotypes in the Mouse Brain

In plain English

AI plain-English summary

A faulty gene causes severe Rett Syndrome symptoms in mice, but switching that gene back on reverses the damage. This finding, published last year by the same team, overturned the long-held assumption that Rett Syndrome—a severe autism-related condition affecting around 1% of children—causes permanent brain damage. The researchers now want to understand exactly how reversible the condition is. They will apply sensitive behavioural and neurological tests to mice to measure which specific symptoms—such as repetitive hand movements, loss of speech, and intellectual disability—can be fully rescued, and which brain regions control each symptom. This matters because Rett Syndrome is unusual among autism-related disorders: its root cause is almost always a mutation in a single gene, MECP2. Most other autism-linked conditions have unknown genetic causes, making them harder to study. If the team can map specific symptoms to specific brain regions, they could identify targets for future therapies. This is fundamental science with no immediate clinical application, but the principle that a severe neurodevelopmental disorder might be reversible in humans could eventually change how doctors think about treating not just Rett Syndrome, but potentially other autism-related conditions.

View original technical description
Autism includes a family of brain conditions that affect about 1% of all children. While there is strong evidence that these disorders are genetic in origin, the genes responsible are in almost all cases unknown. Rett Syndrome belongs to the autism family because affected individuals show late onset symptoms including repetitive hand movements, lack of speech and mental retardation. Rett is exceptional, however, because we know that the root cause is virtually always due to mutation of a known gene: MECP2. Mice that have the same mutation show symptoms very similar to Rett Syndrome, permitting us to study the disease in depth. We made the surprising finding last year that mice with advanced Rett-like symptoms could be rescued by switching on the MECP2 gene. In other words Rett Syndrome, in mice at least, is highly reversible. Here we wish to build on that study by applying sensitive tests for many aspects of brain function. Using these tests will be able to see how reversible each Rett-like symptom is and to find out which region of the brain is responsible. By mapping symptoms onto the brain in this way, we hope to set the stage for targeted therapies that may treat specific defects in Rett and perhaps related autistic conditions.

View the original record at the funder ↗

Researchers

Adrian Bird (Principal Investigator)Gernot Riedel (Co-Investigator)Jim Selfridge (Co-Investigator)Leanne Campbell McKay (Co-Investigator)Stuart Cobb (Co-Investigator)

Related Research

Grants with similar aims, by meaning.

Neural network alterations in Rett Syndrome
Imaging macroscopic cortical dynamics to understand sensorimotor dysfunction and recovery in a mouse model of Rett Syndrome
Developing and evaluating novel gene therapy approaches in Rett syndrome
Neuronal oscillations in disease
Towards understanding and treatment of MeCP2-related disorders.

Original classification

Research Grant

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.